Parkinson's disease: an update on pathogenesis and treatment

被引：28
作者：
Foltynie, Tom [1 ,2 ]
Kahan, Joshua [2 ]
机构：
[1] Natl Hosp Neurol & Neurosurg, Box 146,Queen Sq, London WC1N 3BG, England
[2] UCL Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷 / 05期
关键词：
Parkinson's disease; Pathogenesis; Treatment; Update; ALPHA-SYNUCLEIN; NEUROTROPHIC FACTOR; SUBSTANTIA-NIGRA; CONTROLLED-TRIAL; DOPAMINERGIC-NEURONS; RODENT MODELS; GENE-THERAPY; COMPLEX-I; GLUCOCEREBROSIDASE; BRAIN;
D O I：
10.1007/s00415-013-6915-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The Parkinson's disease research field is a rapidly moving one, as many of the relevant processes underlying PD neurodegeneration are being deciphered, enabling novel approaches to treatment to be assessed both in the laboratory and in the clinic. This review aims to highlight the most relevant updates in the PD field, with emphasis on research that may help lead towards an improvement in the treatment of this condition.
引用
收藏
页码：1433 / 1440
页数：8
相关论文
共 76 条
  • [51] Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
    Mogi, M
    Togari, A
    Kondo, T
    Mizuno, Y
    Komure, O
    Kuno, S
    Ichinose, H
    Nagatsu, T
    [J]. NEUROSCIENCE LETTERS, 1999, 270 (01) : 45 - 48
  • [52] Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains
    Mogi, M
    Togari, A
    Kondo, T
    Mizuno, Y
    Kogure, O
    Kuno, S
    Ichinose, H
    Nagatsu, T
    [J]. NEUROSCIENCE LETTERS, 2001, 300 (03) : 179 - 181
  • [53] Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
    Müftüoglu, M
    Elibol, B
    Dalmizrak, O
    Ercan, A
    Kulaksiz, G
    Ögüs, H
    Dalkara, T
    Özer, N
    [J]. MOVEMENT DISORDERS, 2004, 19 (05) : 544 - 548
  • [54] Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
    Nalls, Michael A.
    Plagnol, Vincent
    Hernandez, Dena G.
    Sharma, Manu
    Sheerin, Una-Marie
    Saad, Mohamad
    Simon-Sanchez, Javier
    Schulte, Claudia
    Lesage, Suzanne
    Sveinbjornsdottir, Sigurlaug
    Arepalli, Sampath
    Barker, Roger
    Ben-Shlomo, Yoav
    Berendse, Henk W.
    Berg, Daniela
    Bhatia, Kailash
    de Bie, Rob M. A.
    Biffi, Alessandro
    Bloem, Bas
    Bochdanovits, Zoltan
    Bonin, Michael
    Bras, Jose M.
    Brockmann, Kathrin
    Brooks, Janet
    Burn, David J.
    Charlesworth, Gavin
    Chen, Honglei
    Chinnery, Patrick F.
    Chong, Sean
    Clarke, Carl E.
    Cookson, Mark R.
    Cooper, J. Mark
    Corvol, Jean Christophe
    Counsell, Carl
    Damier, Philippe
    Dartigues, Jean-Francois
    Deloukas, Panos
    Deuschl, Guenther
    Dexter, David T.
    van Dijk, Karin D.
    Dillman, Allissa
    Durif, Frank
    Duerr, Alexandra
    Edkins, Sarah
    Evans, Jonathan R.
    Foltynie, Thomas
    Gao, Jianjun
    Gardner, Michelle
    Gibbs, J. Raphael
    Goate, Alison
    [J]. LANCET, 2011, 377 (9766) : 641 - 649
  • [55] Why Have We Failed to Achieve Neuroprotection in Parkinson's Disease?
    Olanow, C. Warren
    Kleburtz, Karl
    Schapira, Anthony H. V.
    [J]. ANNALS OF NEUROLOGY, 2008, 64 (06) : S101 - S110
  • [56] Olanow CW, RANDOMIZED DOUBLE BL
  • [57] Istradefylline for the treatment of Parkinson's disease
    Park, Ariane
    Stacy, Mark
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (01) : 111 - 114
  • [58] Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
    Perry, T
    Haughey, NJ
    Mattson, MP
    Egan, JM
    Greig, NH
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) : 881 - 888
  • [59] A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
    Plagnol, Vincent
    Nalls, Michael A.
    Bras, Jose M.
    Hernandez, Dena G.
    Sharma, Manu
    Sheerin, Una-Marie
    Saad, Mohamad
    Simon-Sanchez, Javier
    Schulte, Claudia
    Lesage, Suzanne
    Sveinbjornsdottir, Sigurlaug
    Amouyel, Philippe
    Arepalli, Sampath
    Band, Gavin
    Barker, Roger A.
    Bellinguez, Celine
    Ben-Shlomo, Yoav
    Berendse, Henk W.
    Berg, Daniela
    Bhatia, Kailash
    de Bie, Rob M. A.
    Biffi, Alessandro
    Bloem, Bas
    Bochdanovits, Zoltan
    Bonin, Michael
    Brockmann, Kathrin
    Brooks, Janet
    Burn, David J.
    Charlesworth, Gavin
    Chen, Honglei
    Chinnery, Patrick F.
    Chong, Sean
    Clarke, Carl E.
    Cookson, Mark R.
    Cooper, J. Mark
    Corvol, Jean Christophe
    Counsell, Carl
    Damier, Philippe
    Dartigues, Jean-Francois
    Deloukas, Panos
    Deuschl, Guenther
    Dexter, David T.
    van Dijk, Karin D.
    Dillman, Allissa
    Durif, Frank
    Duerr, Alexandra
    Edkins, Sarah
    Evans, Jonathan R.
    Foltynie, Thomas
    Freeman, Colin
    [J]. PLOS GENETICS, 2011, 7 (06):
  • [60] Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
    Polymeropoulos, MH
    Lavedan, C
    Leroy, E
    Ide, SE
    Dehejia, A
    Dutra, A
    Pike, B
    Root, H
    Rubenstein, J
    Boyer, R
    Stenroos, ES
    Chandrasekharappa, S
    Athanassiadou, A
    Papapetropoulos, T
    Johnson, WG
    Lazzarini, AM
    Duvoisin, RC
    DiIorio, G
    Golbe, LI
    Nussbaum, RL
    [J]. SCIENCE, 1997, 276 (5321) : 2045 - 2047
12345678